Skip to Content

152 Results Found

  • Review
  • Open Access
200 Citations
18,785 Views
19 Pages

DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents

  • Maria Valeria Raimondi,
  • Ornella Randazzo,
  • Mery La Franca,
  • Giampaolo Barone,
  • Elisa Vignoni,
  • Daniela Rossi and
  • Simona Collina

22 March 2019

Dihydrofolate reductase inhibitors are an important class of drugs, as evidenced by their use as antibacterial, antimalarial, antifungal, and anticancer agents. Progress in understanding the biochemical basis of mechanisms responsible for enzyme sele...

  • Article
  • Open Access
391 Views
17 Pages

Persistent and Circulating Plasmodium falciparum dhfr and dhps Mutations in Busia County, Western Kenya

  • Loise Ndung’u,
  • Kelvin Thiong’o,
  • Lewis Karani,
  • Stephen Gitahi,
  • Francis Kimani,
  • Mathew Piero Ngugi and
  • Daniel Kiboi

20 February 2026

Malaria in pregnancy remains a major driver of poor maternal and neonatal health outcomes in sub-Saharan Africa. For decades, intermittent preventive treatment in pregnancy (IPTp), with sulphadoxine-pyrimethamine (SP), has mitigated malaria-associate...

  • Article
  • Open Access
2 Citations
2,935 Views
15 Pages

Slipknot or Crystallographic Error: A Computational Analysis of the Plasmodium falciparum DHFR Structural Folds

  • Rolland B. Tata,
  • Ali F. Alsulami,
  • Olivier Sheik Amamuddy,
  • Tom L. Blundell and
  • Özlem Tastan Bishop

28 January 2022

The presence of protein structures with atypical folds in the Protein Data Bank (PDB) is rare and may result from naturally occurring knots or crystallographic errors. Proper characterisation of such folds is imperative to understanding the basis of...

  • Article
  • Open Access
6 Citations
3,472 Views
24 Pages

Hybrid Caffeic Acid-Based DHFR Inhibitors as Novel Antimicrobial and Anticancer Agents

  • Renu Sehrawat,
  • Ritu Pasrija,
  • Priyanka Rathee,
  • Deepika Kumari,
  • Anurag Khatkar,
  • Esra Küpeli Akkol and
  • Eduardo Sobarzo-Sánchez

A novel series of 1,2,4-triazole analogues of caffeic acid was designed, synthesized, characterized, and assessed for their capacity to inhibit DHFR, as well as their anticancer and antimicrobial properties. A molecular docking analysis was conducted...

  • Article
  • Open Access
4 Citations
2,466 Views
22 Pages

Identification of Active Compounds against Melanoma Growth by Virtual Screening for Non-Classical Human DHFR Inhibitors

  • Andrés Felipe Vásquez,
  • Luis Alberto Gómez,
  • Andrés González Barrios and
  • Diego M. Riaño-Pachón

11 November 2022

Antifolates such as methotrexate (MTX) have been largely known as anticancer agents because of their role in blocking nucleic acid synthesis and cell proliferation. Their mechanism of action lies in their ability to inhibit enzymes involved in the fo...

  • Article
  • Open Access
1 Citations
4,592 Views
24 Pages

Machine-Learning- and Structure-Based Virtual Screening for Selecting Cinnamic Acid Derivatives as Leishmania major DHFR-TS Inhibitors

  • Maria Camila Muñoz-Vega,
  • Sofía López-Hernández,
  • Adrián Sierra-Chavarro,
  • Marcus Tullius Scotti,
  • Luciana Scotti,
  • Ericsson Coy-Barrera and
  • Chonny Herrera-Acevedo

28 December 2023

The critical enzyme dihydrofolate reductase-thymidylate synthase in Leishmania major (LmDHFR-TS) serves a dual-purpose role and is essential for DNA synthesis, a cornerstone of the parasite’s reproductive processes. Consequently, the developmen...

  • Article
  • Open Access
1 Citations
2,719 Views
11 Pages

In 2013, an epidemic of falciparum malaria involving over 820 persons unexpectedly broke out in Shanglin County, Guangxi Zhuang Autonomous Region, China, after a large number of migrant workers returned from Ghana, where they worked as gold miners. H...

  • Article
  • Open Access
15 Citations
3,920 Views
18 Pages

Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors

  • M. Akiful Haque,
  • Akash Marathakam,
  • Ritesh Rana,
  • Samar J Almehmadi,
  • Vishal B. Tambe,
  • Manoj S. Charde,
  • Fahadul Islam,
  • Falak A. Siddiqui,
  • Giulia Culletta and
  • Sharuk L. Khan
  • + 2 authors

4 January 2023

The present work describes the design and development of seventeen pyrimidine-clubbed benzimidazole derivatives as potential dihydrofolate reductase (DHFR) inhibitors. These compounds were filtered by using ADMET, drug-likeness characteristics calcul...

  • Article
  • Open Access
40 Citations
8,159 Views
21 Pages

Eighteen previously undescribed trimethoprim (TMP) analogs containing amide bonds (1–18) were synthesized and compared with TMP, methotrexate (MTX), and netropsin (NT). These compounds were designed as potential minor groove binding agents (MGBAs) an...

  • Article
  • Open Access
16 Citations
4,798 Views
20 Pages

Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS)

  • Veronica Tisato,
  • Paola Muggeo,
  • Tracy Lupiano,
  • Giovanna Longo,
  • Maria Luisa Serino,
  • Massimo Grassi,
  • Ermanno Arcamone,
  • Paola Secchiero,
  • Giorgio Zauli and
  • Donato Gemmati
  • + 1 author

22 August 2019

Childhood acute lymphoblastic leukemia (ALL) peaks around age 2–4, and in utero genetic epigenetic mother-fetus crosstalk might tune ALL onset during childhood life. Folate genes variably interact with vitamin status on ALL risk and prognosis....

  • Article
  • Open Access
61 Citations
6,960 Views
31 Pages

Herein, a series of novel hybrid sulfaguanidine moieties, bearing 2-cyanoacrylamide 2ad, pyridine-2-one 310, and 2-imino-2H-chromene-3-carboxamide 11, 12 derivatives, were synthesized, and their structure confirmed by spectral data and elemental an...

  • Article
  • Open Access
78 Citations
6,611 Views
23 Pages

A series of Bis-pyrazole Schiff bases (6ad and 7ad) and mono-pyrazole Schiff bases (8ad and 9ad) were designed and synthesized through the reaction of 5-aminopyrazoles 1ad with aldehydes 25 using mild reactio...

  • Article
  • Open Access
1,314 Views
21 Pages

Development of QSAR Models and Web Applications for Predicting hDHFR Inhibitor Bioactivity Using Machine Learning

  • Ibrahim Maattallaoui,
  • Mahamadou Sakho,
  • Abdellah Maatallaoui,
  • Enrique Barrajón-Catalán and
  • Noureddine El Aouad

1 December 2025

Human dihydrofolate reductase (hDHFR) is a crucial cellular enzyme in folate metabolic pathway, where it catalyzes the reduction of dihydrofolate into tetrahydrofolate (THF) and an important cofactor involved in DNA, RNA, protein biosynthesis and cel...

  • Article
  • Open Access
5 Citations
4,095 Views
11 Pages

15 September 2017

Dihydrofolate reductase (DHFR), an essential enzyme in the folate pathway, is a potential target for new anti-tuberculosis drugs. Fifteen crystal structures of Mycobacterium tuberculosis DHFR complexed with NADPH and various inhibitors are available...

  • Article
  • Open Access
10 Citations
3,713 Views
20 Pages

Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine in Pregnancy: Low Coverage and High Prevalence of Plasmodium falciparum dhfr-dhps Quintuple Mutants as Major Challenges in Douala, an Urban Setting in Cameroon

  • Carole Else Eboumbou Moukoko,
  • Loick Pradel Kojom Foko,
  • Angèle Ayina,
  • Bernard Tornyigah,
  • Annie Rachel Epote,
  • Ida Calixte Penda,
  • Patricia Epee Eboumbou,
  • Serge Bruno Ebong,
  • Gaetan Texier and
  • Albert Same Ekobo
  • + 3 authors

Intermittent preventive treatment in pregnancy with sulfadoxine and pyrimethamine (IPTp-SP) is a key component in the malaria control strategy implemented in Africa. The aim of this study was to determine IPTp-SP adherence and coverage, and the impac...

  • Article
  • Open Access
7 Citations
4,811 Views
22 Pages

Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity

  • Jennifer I. Brown,
  • Peng Wang,
  • Alan Y. L. Wong,
  • Boryana Petrova,
  • Rosanne Persaud,
  • Sepideh Soukhtehzari,
  • Melanie Lopez McDonald,
  • Danielle Hanke,
  • Josephine Christensen and
  • Brent D. G. Page
  • + 6 authors

19 January 2023

Dihydrofolate reductase (DHFR) is an established anti-cancer drug target whose inhibition disrupts folate metabolism and STAT3-dependent gene expression. Cycloguanil was proposed as a DHFR inhibitor in the 1950s and is the active metabolite of clinic...

  • Article
  • Open Access
7 Citations
2,991 Views
16 Pages

DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action

  • Daniela Iaconis,
  • Francesca Caccuri,
  • Candida Manelfi,
  • Carmine Talarico,
  • Antonella Bugatti,
  • Federica Filippini,
  • Alberto Zani,
  • Rubina Novelli,
  • Maria Kuzikov and
  • Marcello Allegretti
  • + 8 authors

9 May 2023

During the COVID-19 pandemic, drug repurposing represented an effective strategy to obtain quick answers to medical emergencies. Based on previous data on methotrexate (MTX), we evaluated the anti-viral activity of several DHFR inhibitors in two cell...

  • Article
  • Open Access
5 Citations
2,882 Views
13 Pages

Therapeutic strategies for rare diseases based on exon skipping are aimed at mediating the elimination of mutated exons and restoring the reading frame of the affected protein. We explored the capability of polypurine reverse-Hoogsteen hairpins (PPRH...

  • Article
  • Open Access
6 Citations
2,882 Views
17 Pages

Kaurane-Type Diterpenoids as Potential Inhibitors of Dihydrofolate Reductase-Thymidylate Synthase in New World Leishmania Species

  • Chonny Herrera-Acevedo,
  • Renata Priscila Barros de Menezes,
  • Natália Ferreira de Sousa,
  • Luciana Scotti,
  • Marcus Tullius Scotti and
  • Ericsson Coy-Barrera

The bifunctional enzyme Dihydrofolate reductase-thymidylate synthase (DHFR-TS) plays a crucial role in the survival of the Leishmania parasite, as folates are essential cofactors for purine and pyrimidine nucleotide biosynthesis. However, DHFR inhibi...

  • Article
  • Open Access
1 Citations
3,589 Views
15 Pages

Phosphorylation of Thymidylate Synthase and Dihydrofolate Reductase in Cancer Cells and the Effect of CK2α Silencing

  • Patrycja Wińska,
  • Anna Sobiepanek,
  • Katarzyna Pawlak,
  • Monika Staniszewska and
  • Joanna Cieśla

3 February 2023

Our previous research suggests an important regulatory role of CK2-mediated phosphorylation of enzymes involved in the thymidylate biosynthesis cycle, i.e., thymidylate synthase (TS), dihydrofolate reductase (DHFR), and serine hydroxymethyltransferas...

  • Article
  • Open Access
3 Citations
9,745 Views
15 Pages

Interaction Energy Analysis of Nonclassical Antifolates with Pneumocystis carinii Dihydrofolate Reductase

  • Conrad Pitts,
  • Jian Yin,
  • Donnell Bowen,
  • Celia J. Maxwell and
  • William M. Southerland

30 November 2002

The x-ray structure of the Pneumocystis carinii dihydrofolate reductase (DHFR):trimethoprim:NADPH ternary complex obtained from the Protein Databank was used as a structural template to generate models for the following complexes: P. carinii DHFR:pir...

  • Article
  • Open Access
1 Citations
3,507 Views
13 Pages

Site-Specific Tryptophan Labels Reveal Local Microsecond–Millisecond Motions of Dihydrofolate Reductase

  • Morgan B. Vaughn,
  • Chloe Biren,
  • Qun Li,
  • Ashwin Ragupathi and
  • R. Brian Dyer

22 August 2020

Many enzymes are known to change conformations during their catalytic cycle, but the role of these protein motions is not well understood. Escherichia coli dihydrofolate reductase (DHFR) is a small, flexible enzyme that is often used as a model syste...

  • Communication
  • Open Access
513 Views
14 Pages

Interpretability of Deep High-Frequency Residuals: A Case Study on SAR Splicing Localization

  • Edoardo Daniele Cannas,
  • Sara Mandelli,
  • Paolo Bestagini and
  • Stefano Tubaro

28 September 2025

Multimedia Forensics (MMF) investigates techniques to automatically assess the integrity of multimedia content, e.g., images, videos, or audio clips. Data-driven methodologies like Neural Networks (NNs) represent the state of the art in the field. De...

  • Article
  • Open Access
3 Citations
4,546 Views
17 Pages

Studies on the Interaction between Poly-Phosphane Gold(I) Complexes and Dihydrofolate Reductase: An Interplay with Nicotinamide Adenine Dinucleotide Cofactor

  • Stefania Pucciarelli,
  • Silvia Vincenzetti,
  • Massimo Ricciutelli,
  • Oumarou Camille Simon,
  • Anna Teresa Ramadori,
  • Lorenzo Luciani and
  • Rossana Galassi

A class of gold(I) phosphane complexes have been identified as inhibitors of dihydrofolate reductase (DHFR) from E. coli, an enzyme that catalyzes the reduction of dihydrofolate (DHF) to tetrahydrofolate (THF), using NADPH as a coenzyme. In this work...

  • Article
  • Open Access
8 Citations
1 Views
4 Pages

Prevalence of Dihydrofolate Reductase Gene Mutations in Plasmodium falciparum Isolate from Pregnant Women in Nigeria

  • Olusola Ojurongbe,
  • Bukola D. Tijani,
  • Adegboyega A. Fawole,
  • Oluwaseyi A. Adeyeba and
  • Juergen F. Kun

We assessed the prevalence of Plasmodium falciparum and the frequency of the dhfr triple mutation that is associated with antifolate drug resistance among P. falciparumisolates obtained from pregnant women in Ilorin, Nigeria. The study included 179 w...

  • Article
  • Open Access
11 Citations
3,905 Views
38 Pages

Preliminary Structure–Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of Trypanosoma brucei brucei

  • Darline Dize,
  • Rolland Bantar Tata,
  • Rodrigue Keumoe,
  • Rufin Marie Kouipou Toghueo,
  • Mariscal Brice Tchatat,
  • Cyrille Ngansop Njanpa,
  • Vianey Claire Tchuenguia,
  • Lauve Tchokouaha Yamthe,
  • Patrick Valere Tsouh Fokou and
  • Fabrice Fekam Boyom
  • + 3 authors

4 October 2022

New drugs are urgently needed for the treatment of human African trypanosomiasis (HAT). In line with our quest for novel inhibitors of trypanosomes, a small library of analogs of the antitrypanosomal hit (MMV675968) available at MMV as solid material...

  • Article
  • Open Access
23 Citations
6,491 Views
25 Pages

1 January 2019

Pteridine reductase 1 (PTR1) is a trypanosomatid multifunctional enzyme that provides a mechanism for escape of dihydrofolate reductase (DHFR) inhibition. This is because PTR1 can reduce pterins and folates. Trypanosomes require folates and pterins f...

  • Article
  • Open Access
3 Citations
3,344 Views
17 Pages

Human dihydrofolate reductase (hDHFR) is an essential cellular enzyme, and inhibiting its activity is a promising strategy for cancer therapy. We have chosen the trimethoprim molecule (TMP) as a model compound in our search for a new class of hDHFR i...

  • Article
  • Open Access
7 Citations
4,243 Views
20 Pages

Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases

  • Matteo Santucci,
  • Rosaria Luciani,
  • Eleonora Gianquinto,
  • Cecilia Pozzi,
  • Flavio di Pisa,
  • Lucia dello Iacono,
  • Giacomo Landi,
  • Lorenzo Tagliazucchi,
  • Stefano Mangani and
  • Maria Paola Costi
  • + 1 author

30 November 2021

Three open-source anti-kinetoplastid chemical boxes derived from a whole-cell phenotypic screening by GlaxoSmithKline (Tres Cantos Anti-Kinetoplastid Screening, TCAKS) were exploited for the discovery of a novel core structure inspiring new treatment...

  • Article
  • Open Access
17 Citations
3,520 Views
20 Pages

In Vitro and In Silico Analysis of the Anticancer Effects of Eurycomanone and Eurycomalactone from Eurycoma longifolia

  • Nurhanan Murni Yunos,
  • Habibah A. Wahab,
  • Mohammad G. Al-Thiabat,
  • Nor Jannah Sallehudin and
  • Muhamad Haffiz Jauri

31 July 2023

Eurycomanone and eurycomalactone are known quassinoids present in the roots and stems of Eurycoma longifolia. These compounds had been reported to have cytotoxic effects, however, their mechanism of action in a few cancer cell lines have yet to be el...

  • Article
  • Open Access
9 Citations
4,249 Views
17 Pages

In this study, a new series of 4-(2,5-dimethyl-1H-pyrrol-1-yl)-N’-(2-(substituted)acetyl) benzohydrazides (5a–n) were prepared and new heterocycles underwent thorough characterization and evaluation for antibacterial activity; some of the...

  • Article
  • Open Access
7 Citations
8,448 Views
23 Pages

Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer

  • Junbiao Wang,
  • Daniela Beghelli,
  • Augusto Amici,
  • Stefania Sut,
  • Stefano Dall’Acqua,
  • Giulio Lupidi,
  • Diego Dal Ben,
  • Onelia Bistoni,
  • Daniele Tomassoni and
  • Cristina Marchini
  • + 4 authors

17 November 2024

Inonotus obliquus (Chaga) is a medicinal mushroom with several pharmacological properties that is used as a tea in traditional Chinese medicine. In this study, Chaga water extract was digested in vitro to mimic the natural processing and absorption o...

  • Article
  • Open Access
3 Citations
3,853 Views
9 Pages

Theoretical Investigation of the Enantioselective Complexations between pfDHFR and Cycloguanil Derivatives

  • Suriyawut Kulatee,
  • Pisanu Toochinda,
  • Anotai Suksangpanomrung and
  • Luckhana Lawtrakul

21 November 2017

Point mutations in Plasmodium falciparum dihydrofolate reductase (pfDHFR), especially the double mutant variant (A16V + S108T), led to ineffective inhibiting by cycloguanil (Cyc). Cycloguanil derivatives showed good inhibiting properties against wild...

  • Article
  • Open Access
2 Citations
2,747 Views
23 Pages

Genomic and Phenotypic Characterization of CHO 4BGD Cells with Quad Knockout and Overexpression of Two Housekeeping Genes That Allow for Metabolic Selection and Extended Fed-Batch Culturing

  • Nadezhda Alexandrovna Orlova,
  • Maria Valerievna Sinegubova,
  • Denis Eduardovich Kolesov,
  • Yulia Alexandrovna Khodak,
  • Victor Vyacheslavovich Tatarskiy and
  • Ivan Ivanovich Vorobiev

11 May 2025

Re-engineering of CHO cells using genome editing and the overexpression of multiple helper genes is the central track for obtaining better cell lines for the production of biopharmaceuticals. Using two subsequent rounds of genome editing of the CHO S...

  • Communication
  • Open Access
962 Views
13 Pages

Synthesis and In Vitro Pharmacological Evaluation of 5,8-Dideaza Analogs of Methotrexate

  • Marta Abellán-Flos,
  • Charles Skarbek,
  • Dáire J. Gibbons,
  • Estelle Rascol,
  • Ainhoa García and
  • Raphaël Labruère

27 June 2025

This study describes the synthesis of a series of dideaza analogs of methotrexate and their preliminary pharmacological and metabolic evaluation. The 5,8-dideazamethotrexate was efficiently obtained in five steps using a new synthetic route. Oxygenat...

  • Short Note
  • Open Access
1,592 Views
8 Pages

2-(Butylamino)-6-chloro-4-[3-(7-chloro-4-quinolylamino)propylamino]-1,3,5-triazine

  • Zimo Ren,
  • Yuzhu Guo,
  • Yang Xiao,
  • Alessandra Gianoncelli,
  • Paolo Coghi and
  • Giovanni Ribaudo

8 October 2024

We herein report the synthesis of a 7-chloro-aminoquinoline triazine conjugate. The s-triazine library was generated by stepwise nucleophilic substitution of cyanuric chloride with butylamine. The structure of the compound was comprehensively determi...

  • Communication
  • Open Access
21 Citations
9,386 Views
12 Pages

Characterization of Ambrette Seed Oil and Its Mode of Action in Bacteria

  • Selvaraj Arokiyaraj,
  • Seong Ho Choi,
  • Yoonseok Lee,
  • Rajaraman Bharanidharan,
  • Villianur Ibrahim Hairul-Islam,
  • Badathala Vijayakumar,
  • Young Kyoon Oh,
  • Vannam Dinesh-Kumar,
  • Savariar Vincent and
  • Kyoung Hoon Kim

29 December 2014

In the present study, chemical composition and the antibacterial mechanism of ambrette seed oil are investigated. Chemical composition of the oil was analysed by gas chromatography-mass spectrometry (GC-MS). Thirty-five compounds were identified and...

  • Article
  • Open Access
39 Citations
5,185 Views
20 Pages

QSAR and Molecular Docking Studies of Pyrimidine-Coumarin-Triazole Conjugates as Prospective Anti-Breast Cancer Agents

  • Arun Kumar Subramani,
  • Amuthalakshmi Sivaperuman,
  • Ramalakshmi Natarajan,
  • Richie R. Bhandare and
  • Afzal B. Shaik

11 March 2022

Cancer is a life-threatening disease and is the second leading cause of death worldwide. Although many drugs are available for the treatment of cancer, survival outcomes are very low. Hence, rapid development of newer anticancer agents is a prime foc...

  • Article
  • Open Access
12 Citations
5,866 Views
21 Pages

In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice

  • Maria Eugénia Marques da Costa,
  • Antonin Marchais,
  • Anne Gomez-Brouchet,
  • Bastien Job,
  • Noémie Assoun,
  • Estelle Daudigeos-Dubus,
  • Olivia Fromigué,
  • Conceição Santos,
  • Birgit Geoerger and
  • Nathalie Gaspar

17 July 2019

Osteosarcoma, the most common bone malignancy with a peak incidence at adolescence, had no survival improvement since decades. Persistent problems are chemo-resistance and metastatic spread. We developed in-vitro osteosarcoma models resistant to chem...

  • Article
  • Open Access
3 Citations
3,492 Views
22 Pages

Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine

  • Hoda Y. Abdallah,
  • Maha E. Ibrahim,
  • Noha M. Abd El-Fadeal,
  • Dina A. Ali,
  • Gehad G. Elsehrawy,
  • Rasha E. Badr and
  • Howayda M. Hassoba

Background: Methotrexate (MTX) is one of the most common medications used for rheumatoid arthritis (RA) treatment. Single-nucleotide polymorphisms (SNPs) could potentially predict variability in therapeutic outcomes. Aim: This study aims to assess th...

  • Article
  • Open Access
10 Citations
3,145 Views
12 Pages

20 November 2021

Proteins from “pressure-loving” piezophiles appear to adapt by greater compressibility via larger total cavity volume. However, larger cavities in proteins have been associated with lower unfolding pressures. Here, dihydrofolate reductase...

  • Article
  • Open Access
4 Citations
3,024 Views
12 Pages

Adaptations for Pressure and Temperature in Dihydrofolate Reductases

  • Ryan W. Penhallurick,
  • Maya D. Durnal,
  • Alliyah Harold and
  • Toshiko Ichiye

Enzymes from extremophilic microbes that live in extreme conditions are generally adapted so that they function under those conditions, although adaptations for extreme temperatures and pressures can be difficult to unravel. Previous studies have sho...

  • Article
  • Open Access
22 Citations
4,766 Views
20 Pages

In Silico Study Probes Potential Inhibitors of Human Dihydrofolate Reductase for Cancer Therapeutics

  • Rabia Mukhtar Rana,
  • Shailima Rampogu,
  • Amir Zeb,
  • Minky Son,
  • Chanin Park,
  • Gihwan Lee,
  • Sanghwa Yoon,
  • Ayoung Baek,
  • Sarvanan Parameswaran and
  • Keun Woo Lee
  • + 1 author

11 February 2019

Dihydrofolate reductase (DHFR) is an essential cellular enzyme and thereby catalyzes the reduction of dihydrofolate to tetrahydrofolate (THF). In cancer medication, inhibition of human DHFR (hDHFR) remains a promising strategy, as it depletes THF and...

  • Article
  • Open Access
27 Citations
6,438 Views
17 Pages

Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling

  • Alfredo Juárez-Saldivar,
  • Michael Schroeder,
  • Sebastian Salentin,
  • V. Joachim Haupt,
  • Emma Saavedra,
  • Citlali Vázquez,
  • Francisco Reyes-Espinosa,
  • Verónica Herrera-Mayorga,
  • Juan Carlos Villalobos-Rocha and
  • Gildardo Rivera
  • + 2 authors

Chagas disease, caused by Trypanosoma cruzi (T. cruzi), affects nearly eight million people worldwide. There are currently only limited treatment options, which cause several side effects and have drug resistance. Thus, there is a great need for a no...

  • Article
  • Open Access
6 Citations
3,025 Views
26 Pages

29 January 2023

Dihydrofolate reductase (DHFR) is a crucial enzyme that maintains the levels of 5,6,7,8-tetrahydrofolate (THF) required for the biological synthesis of the building blocks of DNA, RNA, and proteins. Over-activation of DHFR results in the progression...

  • Article
  • Open Access
27 Citations
7,043 Views
22 Pages

In Silico Study Identified Methotrexate Analog as Potential Inhibitor of Drug Resistant Human Dihydrofolate Reductase for Cancer Therapeutics

  • Rabia Mukhtar Rana,
  • Shailima Rampogu,
  • Noman Bin Abid,
  • Amir Zeb,
  • Shraddha Parate,
  • Gihwan Lee,
  • Sanghwa Yoon,
  • Yumi Kim,
  • Donghwan Kim and
  • Keun Woo Lee

31 July 2020

Drug resistance is a core issue in cancer chemotherapy. A known folate antagonist, methotrexate (MTX) inhibits human dihydrofolate reductase (hDHFR), the enzyme responsible for the catalysis of 7,8-dihydrofolate reduction to 5,6,7,8-tetrahydrofolate,...

  • Article
  • Open Access
1 Citations
2,027 Views
17 Pages

Michael Adduct of Sulfonamide Chalcone Targets Folate Metabolism in Brugia Malayi Parasite

  • Priyanka S. Bhoj,
  • Sandeep P. Bahekar,
  • Shambhavi Chowdhary,
  • Namdev S. Togre,
  • Nitin P. Amdare,
  • Lingaraj Jena,
  • Kalyan Goswami and
  • Hemant Chandak

A series of Michael adducts of malononitrile and sulfonamide chalcones were synthesized, characterized, and evaluated for their antifilarial activity. Out of 14 compounds, N-(4-(4,4-dicyano-3-p-tolylbutanoyl)phenyl)benzenesulfonamide showed favorable...

  • Article
  • Open Access
9 Citations
3,764 Views
12 Pages

Suicidal Leishmania

  • Lucie Podešvová,
  • Tereza Leštinová,
  • Eva Horáková,
  • Julius Lukeš,
  • Petr Volf and
  • Vyacheslav Yurchenko

25 January 2020

Leishmania are obligate intracellular parasites known to have developed successful ways of efficient immunity evasion. Because of this, leishmaniasis, a disease caused by these flagellated protists, is ranked as one of the most serious tropical infec...

  • Article
  • Open Access
6 Citations
7,758 Views
16 Pages

Synthesis and Biological Evaluation of 2,4-Diaminopyrimidine-Based Antifolate Drugs against Bacillus anthracis

  • Baskar Nammalwar,
  • N. Prasad Muddala,
  • Christina R. Bourne,
  • Mary Henry,
  • Philip C. Bourne,
  • Richard A. Bunce,
  • Esther W. Barrow,
  • K. Darrell Berlin and
  • William W. Barrow

17 March 2014

Due to the innate ability of bacteria to develop resistance to available antibiotics, there is a critical need to develop new agents to treat more resilient strains. As a continuation of our research in this area, we have synthesized a series of race...

  • Article
  • Open Access
6 Citations
6,324 Views
23 Pages

Evaluation of New Dihydrophthalazine-Appended 2,4-Diaminopyrimidines against Bacillus anthracis: Improved Syntheses Using a New Pincer Complex

  • Nagendra Prasad Muddala,
  • Baskar Nammalwar,
  • Subhashini Selvaraju,
  • Christina R. Bourne,
  • Mary Henry,
  • Richard A. Bunce,
  • K. Darrell Berlin,
  • Esther W. Barrow and
  • William W. Barrow

21 April 2015

The synthesis and evaluation of ten new dihydrophthalazine-appended 2,4-diaminopyrimidines as potential drugs to treat Bacillus anthracis is reported. An improved synthesis utilizing a new pincer catalyst, dichlorobis[1-(dicyclohexylphosphanyl)-pipe...

of 4